Biotech · Private company
Laboratoire français de Fractionnement et de Biotechnologies
Track this companyFree. Adds Laboratoire français de Fractionnement et de Biotechnologies to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Coagulation Factor VIIa (Recombinant)Phase 3 · HemophiliaClinicalTrials.gov · fetched Nov 12, 2026
- Coagulation FVIIa (Recombinant)Phase 3 · Hemophilia A With InhibitorsClinicalTrials.gov · fetched Nov 12, 2026
- SEVENFACT®HemophiliaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531)PHASE2 · RECRUITING · started Oct 2, 2025ClinicalTrials.gov NCT07136857 · fetched Nov 12, 2026
- Safety and Efficacy of FVIIa to Prevent Excessive Bleeding in Hemophilia Patients With Inhibitors Undergoing Major SurgeryPHASE3 · TERMINATED · started Jun 7, 2024ClinicalTrials.gov NCT05695391 · fetched Nov 12, 2026
- Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT®COMPLETED · started Nov 7, 2023ClinicalTrials.gov NCT05904210 · fetched Nov 12, 2026
- LR769 in Congenital Hemophilia Patients With Inhibitors Undergoing Elective Surgery or Invasive ProceduresPHASE3 · COMPLETED · started Aug 25, 2016ClinicalTrials.gov NCT02548143 · fetched Nov 12, 2026
- A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIaPHASE3 · COMPLETED · started Dec 7, 2015ClinicalTrials.gov NCT02448680 · fetched Nov 12, 2026